In summary, the results of this study indicate that neither the NOD2 c.3020insC variant or the CDKN2A p.A148T polymorphism are associated with the survival of bladder cancer patients regardless of age, cancer family history, smoking status and sex. The gene discussed is CDKN2A; the disease is urinary bladder carcinoma.